More on INSM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+96.5% Growth)
- Ratings (9.4 Score)
- Holders
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (10/30/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

INSM Income Statement

Click line-items for a historical chart and %
License fees
Other expanded access program income, net
Total revenues
Research and development 23.43M
General and administrative
Total operating expenses 37.15M
Operating loss -37.15M
Investment income 138K
Interest expense -769K
Loss before income taxes
Income tax expense 25K
Net loss -37.76M
Less: accretion of beneficial conversion feature
Net loss attributable to common stockholders -37.76M
Basic and diluted net (loss) income attributable to common stockholders per common share (in dollars per share) -0.61
Weighted average basic common shares outstanding (in shares)
Weighted average diluted common shares outstanding (in shares)

Entities mentioned with INSM

View All Entities